Moreover, the composite biomarker of PCT-CRP-NLCR showed more diagnostic efficacy (0.979; 95% CI 0.95–1.00) in distinguishing the infectious and non-infectious lung injuries in AAV patients. This evidence concerns the gene CRP and anti-neutrophil cytoplasmic antibody-associated vasculitis.